GlassScriptPhysician profile
Elana Koss
NPI 1376831339
$120,989.63
in general payments reported to CMS, 2019-2025
6 companies · $34K in 2025
The $34K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,843 · 2020: $2,148 · 2021: $2,824 · 2022: $6,622 · 2023: $46K · 2024: $27K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $47K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Travel and Lodging: $24K · Food and Beverage: $6,288 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $46,650.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $29,252.32 |
| Travel and Lodging | $24,462.65 |
| Food and Beverage | $6,288.26 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $54,047.47 | 2019-2025 | Mitraclip, Triclip, Navitor |
| Medtronic, INC. | $40,809.09 | 2021-2025 | Corevalve Evolut R, Apollotm |
| Edwards Lifesciences Corporation | $25,405.67 | 2019-2025 | Pascal, Evoque, Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $605.67 | 2019-2020 | |
| Boston Scientific Corporation | $100.86 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.87 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elana Koss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.